DuPont de Nemours, Inc. · NYSE:DD
DuPont de Nemours — DuPont — Investor Presentation (October 2014)
43 slides from DuPont de Nemours's investor presentation, October 2014
Slide 1: Shareholder Update October 2014
Shareholder Update October 2014
Slide 2: Regulation G and Forward-Looking Statements
Regulation G The attached charts include company information that does not conform with generally accepted accounting principles (GAAP). Management believes the use of these non-GAAP measures are meaningful to investors because they provide insight with respect to operating results of the company an
Slide 3: DuPont is a Science Company
DuPont is a Science Company DuPont has a 200-year record of creating value for customers and owners by connecting science to the marketplace to create novel solutions the world needs. Today, DuPont is creating higher growth and higher value for shareholders by leveraging advanced science and technol
Slide 4: Discussion Agenda
Discussion Agenda I. DuPont Is Executing On A Plan To Deliver Higher Growth, Higher Value II. Management’s Plan Is Delivering Results III. Management’s Plan Is Aligned With Shareholder Priorities 4
Slide 5: Management Has A Track Record Of Delivering Shareholder Value
Management Has A Track Record Of Delivering Shareholder Value… Share Price Performance 12/31/2008 – 9/30/2014 Capital Returned To Shareholders Total Shareholder Return As of 9/30/14, cumulative dividends exceeded $9B; $80 $5B share repurchase program announced on 1/28/2014 DuPont 253% $71.76 Number
Slide 6: Discussion Agenda
Discussion Agenda I. DuPont Is Executing On A Plan To Deliver Higher Growth, Higher Value II. Management’s Plan Is Delivering Results III. Management’s Plan Is Aligned With Shareholder Priorities 6
Slide 7: Management's Plan: What Shareholders Should Expect From Us
Management’s Plan: What Shareholders Should Expect From Us • Higher growth, higher value through focused strategic priorities • Innovation driven new products and solutions • Accelerated growth in developing markets • Execution and productivity as a way of life • Savings from redesign initiative (“F
Slide 8: DuPont's Strategy To Build Higher Growth, Higher Value
Path to Future Growth DuPont’s Strategy To Build Higher Growth, Higher Value Agriculture & Bio-Based Advanced Nutrition Industrials Materials Extend our leadership Develop world-leading Strengthen and grow our across the high-value, industrial biotechnology leading position in science-driven segment
Slide 9: Strategic Priorities Delivering Growth
Path to Future Growth Strategic Priorities Delivering Growth Agriculture & Nutrition Bio-Based Industrials Advanced Materials • Seeds: Extend germplasm leadership and • Enzymes: Develop and commercialize • Advanced Polymers: Develop drive biotech pipeline for higher crop enzymes providing faster tar
Slide 10: Our Operational Priorities Advance Our Strategic Priorities
Path to Future Growth Our Operational Priorities Advance Our Strategic Priorities Operational Priorities Innovation Global Reach Execution • Leveraging Multi-disciplinary • Driving Penetration In Fast- Science And Technology Platform growing, Developing Markets • Delivering Ongoing Productivity Enha
Slide 11: Capabilities Drive Solutions From Portfolio Renewal To Transformational Innovation
Innovation Our Full Complement Of Capabilities Drives Solutions From Portfolio Renewal To Transformational Innovation The DuPont Innovation Platform: Ongoing DuPont Solutions Global Technical Market Insights Science Capabilities Agriculture Electronics & Market Application Chemistry Communications I
Slide 12: DuPont's Innovation Platform Delivers Continuous, Sustainable Growth
Innovation DuPont’s Innovation Platform Delivers Continuous, Sustainable Growth Focus Examples 3 • Entirely new businesses based on Transformational new technologies and capabilities • Bio-Based Innovation • Open new markets and opportunities opportunities 2 • Expanded capabilities to deliver • Ryna
Slide 13: Pipeline Of Both Step-Change And Transformational Innovations
Innovation Pipeline Of Both Step-Change And Transformational Innovations Significant Growth Initiatives – Selected Examples Agriculture & Nutrition Bio-Based Industrials Advanced Materials • Cyazypyr® Insecticide • Animal Nutrition • Aerospace Innovations • DP4114 Corn • Biobutanol • Kevlar® AP • En
Slide 14: Uniquely Positioned In The Bio-Based Technology Revolution
Innovation DuPont Is Uniquely Positioned To Be At The Forefront Of The Bio-Based Technology Revolution Bio-Based Industrials • Industry pioneer • Enzymology • Protein engineering • Collaborations in food and • Synthetic biology • Hi-throughput screening consumer goods markets • Fermentation science
Slide 15: Developing Markets Represent Significant Opportunities For Growth
Global Reach Developing Markets Represent Significant Opportunities For Growth Rapidly Growing Significant Growth Developing Market Sales(1) in China(1) $4.0 China Sales % of Total DuPont $12.0 8% 34% Sales ($B) $2.3 $9.7 $2.0 4% $9.0 $0.9 $0.0 25% Sales ($B) 2008 2013 $6.0 $5.0 ~6,000 employees She
Slide 16: Enhanced Portfolio Through Major Transactions
Execution Enhanced Portfolio For Higher Growth, Higher Value Through Major Transactions Acquisitions: Divestitures: Technology/Market Access Driven Slower Growth Businesses Performance Coatings 2013 Sales (2013, $5.1B) (2011, $7B) Performance Chemicals (Mid-2015, ~19% of 2013 Sales) Electronics & Co
Slide 17: Committed Focus To Aligning Costs With A Changing Portfolio
Execution Committed Focus To Aligning Costs With A Changing Portfolio As part of the plan to separate Performance Chemicals, Management initiated Optimization of a fresh look at: The Ongoing • Organizational design, business necessities and external benchmarks DuPont • Business processes and optimal
Slide 18: "Fresh Start" Will Have A Significant And Sustainable Benefit
Execution “Fresh Start” Will Have A Significant And Sustainable Benefit Result Target Annual Savings ($MM) • Significant complexity reduction Q4 2015 Cost Reductions with clear accountabilities and Cost Reductions Run Rate in Final State performance measurement Costs Eliminated at • Core functions w
Slide 19: Discussion Agenda
Discussion Agenda I. DuPont Is Executing On A Plan To Deliver Higher Growth, Higher Value II. Management’s Plan Is Delivering Results III. Management’s Plan Is Aligned With Shareholder Priorities 19
Slide 20: Management Has A Strong Track Record Of Delivering Results
Management Has A Strong Track Record Of Delivering Results Clear Strategic Mission… …With Tangible Results Enhanced portfolio 1. Refine the portfolio to achieve Realized innovation successes higher growth with less Strengthened key business lines volatility 2009 – Current Streamlined cost st
Slide 21: Upcoming Performance Chemicals Separation Is Another Key Repositioning Step
Enhanced Portfolio Upcoming Performance Chemicals Separation Is Another Key Repositioning Step DuPont Performance Chemicals • Leading technologies • Leading businesses • Science leverage across businesses • Customer focused applications development • Strong applications development • Low cost produc
Slide 22: New Products Delivered More Than $10 Billion Of Revenue In 2013
Realized Innovation Successes New Products Delivered More Than $10 Billion(1) (28%) Of Revenue In 2013 Agriculture & Nutrition Bio-Based Industrials Advanced Materials • Advanced Polymers • Seeds • Enzymes • Protective Materials • Agricultural Chemicals • Biofuels • Electronic Materials • Specialty
Slide 23: Strategic And Operational Actions Have Resulted In Strong Performance
- Strengthened Key Business Lines Strategic And Operational Actions Have Resulted In Strong Performance Segment Sales (1) Segment Adjusted Operating Earnings (2) $40 $7 Segment Adjusted Operating Earnings ($B) $6 $30 $5 Segment Sales ($B) $4 $20 $3 $2 $10 $1 $0 $0 2008 2011 2013 2008 2011 2013 Agric
Slide 24: DuPont's Businesses Are Competitively Well-Positioned
Strengthened Key Business Lines DuPont’s Businesses Are Competitively Well-Positioned DuPont Improvement 2013 EBITDA Margin (Since 2008) Key Margin Drivers Peer Universe (1) Agriculture 22.6% Competitive with peers; well-positioned for future growth BASF, Bayer, Dow, FMC, +360bps due to industry lea
Slide 25: Cost Management Is Always A Priority
Streamlined Cost Structure Cost Management Is Always A Priority Cost Reductions 2009 – 2013 Cost Saving Initiatives $3B Over $2B cumulative fixed cost savings $2B achieved (exceeded target of $1B(1)), $1B driving segment operating margin $0B improvement 2009 2010 2011 2012 2013 Working Capital Sav
Slide 26: Cost Saving Initiatives Will Further Enhance Overhead Costs
Streamlined Cost Structure Cost Saving Initiatives Will Further Enhance Already Competitive Overhead Costs And Increase DuPont’s Cost Advantage Proxy Peers 35.0% 31.5% 31.1% 30.0% 27.5% 25.0% Average SG&A as a % of Net 22.7% 22.6% 22.2% Sales (CY2009 – CY2013) 20.7% 19.6% 20.0% 18.5% Peer Median: 18
Slide 27: Adjusted Operating Margins Have Significantly Improved
Strong Operating Performance Adjusted Operating Margins Have Significantly Improved +650 bps 2008–2013 Change in Adjusted Operating Margin(1) 16.0% 14.1% +190 9.5% bps 2011–2013 Change in Adjusted Operating Margin(1) 2008 2011 2013 (1) Segment adjusted operating earnings and margins are calculated u
Slide 28: Adjusted Operating Earnings Have More Than Doubled
Strong Operating Performance Adjusted Operating Earnings Have More Than Doubled And EPS Growth Has Significantly Outperformed Both Peers And The Market EPS CAGR(2) Adjusted Operating Earnings After-Tax(1) (CY2008 – CY2013) 5.9% 17.1% 29.1% (3) $3.6B DuPont $0.8B (4) Proxy Peers 2.8% $2.2B S&P (5) 9.
Slide 29: Actions To Strengthen Management Accountability And Align Incentives
Simplified Management DuPont Has Taken Numerous Actions To Strengthen Management Accountability And Align Incentives Quality of Management Improved Compensation Aligned With Performance • Consolidated 23 Business Units into 12 • Short-term incentives include: • Reduced senior leadership by >20% • Re
Slide 30: Capital Return Outperforms Peers
Returned Capital to Shareholders DuPont’s Capital Return Outperforms Peers Given Consistent Increase Of Dividends And Share Repurchases Total Capital Returned to Dividends per Share Capital Returned To Shareholders Shareholders (2009 – 2013)(5) As of 9/30/14, cumulative dividends $1.84 exceeded $9B;
Slide 31: DuPont Has Outperformed Peers And The Market In Total Shareholder Return
Delivered Shareholder Value DuPont Has Outperformed Peers And The Market In Total Shareholder Return Total Shareholder Return (12/31/08 – 9/30/14)(1) DuPont 253% Proxy Peers(2) 125% S&P 217% Chemicals(3) S&P 500 147% (4) S&P Materials 158% Source: Datastream as of 9/30/2014, Bloomberg, Capital IQ, F
Slide 32: Effective Governance Practices Contribute To Value Creation
Accountability and Oversight DuPont’s Effective Governance Practices Contribute To Value Creation • 12 of 13 directors are independent Effective Board • 4 new directors added in the last three years, and 10 directors added in the Leadership and last nine years Independent • Executive sessions of ind
Slide 33: Discussion Agenda
Discussion Agenda I. DuPont Is Executing On A Plan To Deliver Higher Growth, Higher Value II. Management’s Plan Is Delivering Results III. Management’s Plan Is Aligned With Shareholder Priorities 33
Slide 34: Management Actively Engages With Shareholders To Understand Priorities
Management Actively Engages With Shareholders To Understand Priorities And Discuss Improvements Shareholder Priorities Management’s Plan Aggressive and proactive portfolio management Separation of Non-Core Latest step – Performance Chemicals – in process Businesses Business aligned around key
Slide 35: Observations On Proposal For Further Break-Up
Observations On Proposal For Further Break-Up • Trian Fund Management has proposed the further separation of DuPont into two entities – a company focused on our Agriculture & Nutrition businesses and a company focused on our Materials businesses – with substantial additional leverage • Members of Du
Slide 36: Conclusion
Conclusion 36
Slide 37: DuPont's Plan Has Delivered Strong Results
DuPont’s Plan Has Delivered Strong Results Key Areas Results Of Management Actions Returns Outperformance in TSR and total capital returned to shareholders versus peers Track record of exceeding performance targets; Management has exceeded Targets 3-year targets set in 2009 and long-term targets
Slide 38: Management's Plan: What Shareholders Should Expect From Us
Management’s Plan: What Shareholders Should Expect From Us • Higher growth, higher value through focused strategic priorities • Innovation driven new products and solutions • Accelerated growth in developing markets • Execution and productivity as a way of life • Savings from redesign initiative (“F
Slide 39: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures
Slide 40: Reconciliation of Non-GAAP Measures: Segment Sales and Earnings
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED) (dollars in millions) Year Year Year SEGMENT SALES 2013 2011 2008 Total Segment Sales (a) 36,046 34,087 26,499 Less: Performance Chemicals (b) 6,932 8,055 6,245 Less: Other 6 40 160 Tot
Slide 41: Reconciliation of Segment PTOI to Adjusted EBITDA
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED) (dollars in millions) RECONCILIATION OF SEGMENT PRE-TAX OPERATING INCOME (PTOI) TO ADJUSTED EBITDA Electronics & Nutrition & Safety & Performance Performance Industrial Year Ended Decem
Slide 42: Reconciliation of Adjusted Operating Earnings and EPS
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED) (dollars in millions, except per share) Year Year 2013 2008 ADJUSTED OPERATING EARNINGS AFTER INCOME TAXES Income From Continuing Operations After Income Taxes (GAAP) 2,863 2,083 Add: S
Slide 43: Copyright and Trademarks
Copyright © 2014 DuPont. All rights reserved. The DuPont Oval Logo, DuPontTM, The miracles of scienceTM, and all products denoted with ® or M are trademarks or registered trademarks of E. I. du Pont de Nemours and Company. 43